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Purpose: To determine if excess greater left ventricle (LV) trabecu-
lation is associated with decreased average regional myo-
cardial function, diffuse fibrosis, or both.
Materials and 
Methods:
This was a HIPAA-compliant institutional board approved 
multicenter study, and all participants provided written 
informed consent. Participants in the Multi-Ethnic Study 
of Atherosclerosis (MESA) underwent a comprehensive 
cardiac magnetic resonance (MR) examination. LV tra-
beculation was measured with the maximal apical frac-
tal dimension (FD), which is a marker of endocardial 
complexity. Demographic covariates, cardiovascular risk 
factors, and cardiac MR measurements were compared 
across quartiles of FD. Associations between FD and peak 
regional systolic circumferential strain (Ecc) and T1 time, 
a surrogate for diffuse myocardial fibrosis, were assessed 
with multivariable linear regression models.
Results: A total of 1123 subjects (593 [52.8%] female; mean age, 
67.1 years 6 8.7 [standard deviation]) underwent FD and 
Ecc measurement, and 992 (521 [52.5%] female; mean 
age, 67.1 years 6 8.7) underwent FD and T1 measure-
ment. Mean FD was 1.2 6 0.07 in both groups, and mean 
Ecc was 218.3 6 2.27 in the subjects who underwent 
FD and Ecc measurement. Global volumes and ejection 
fraction showed no differences between FD quartiles. 
However, with increasing FD quartile, Ecc was greater 
(indicating worse average regional function) (P , .001). 
After adjustment, greater trabeculation was associated 
with 21% worse myocardial strain (relative to the mean) 
per unit change in FD (regression coefficient = 4.0%; P 
< .001). There was no association between the degree 
of trabeculation and diffuse fibrosis measured with T1 
mapping.
Conclusion: Average regional LV function was worse in individuals 
with greater LV trabeculation, supporting the concept of 
hypertrabeculation being an epiphenomenon of disease.
q RSNA, 2017
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authors had control of all data submit-
ted for publication.
Study Participants
This study was approved by the institu-
tional review boards of each of the par-
ticipating field sites in the United States 
(Wake Forest Univeristy, Winston-Salem, 
NC; Columbia University, New York, NY; 
Johns Hopkins University, Baltimore, 
Md; University of Minnesota, Minne-
apolis, Minn; Northwestern University, 
Evanston, Ill; University of California, Los 
Angeles), and all participants provided 
written informed consent. All sites were 
compliant with the Health Insurance Por-
tability and Accountability Act.
The Multi-Ethnic Study of Athero-
sclerosis (MESA) is an ongoing popula-
tion-based longitudinal study that was 
initiated in July 2000. At enrollment, 
study participants were free of clinically 
recognized cardiovascular disease (16). 
Ten years after baseline examination, 
3015 subjects underwent an additional 
cardiac magnetic resonance (MR) ex-
amination, and a subset of these sub-
jects underwent regional function as-
sessment (using MR imaging tagging), 
late gadolinium enhancement (LGE) 
imaging, and T1 mapping. Participants 
lower contractility compared with that in 
regions of normal myocardium. How-
ever, the relationship of hypertrabecu-
lated myocardium to contractile function 
and fibrosis in individuals without LVNC 
disease is currently unknown.
Calculation of the ratio of the thick-
ness of noncompacted to compacted 
myocardium (NCC) is a simple and fast 
way to quantify trabeculation that is cur-
rently the most widely used technique 
(13). A more comprehensive measure 
of LV trabeculation can be performed 
with fractal analysis (14). The fractal di-
mension (FD) is a unitless index used to 
assess endocardial complexity (14,15). 
The maximal FD in the apical half of the 
LV is higher in patients with LVNC than 
in healthy volunteers (14). When com-
pared with calculation of NCC, the frac-
tal method has been shown to be more 
accurate and reproducible (14).
Although the importance of detecting 
excess trabeculation is reasonably well 
understood in patients with overt LVNC 
disease, the importance of this common 
finding is not understood in individuals 
who do not have overt clinical cardio-
myopathy. Our hypothesis was that myo-
cardial strain is impaired in subjects with 
greater trabeculation and may be associ-
ated with diffuse fibrosis. Thus, the purpose 
of our study was to determine if excess 
greater LV trabeculation is associated 
with decreased average regional myocar-
dial function, diffuse fibrosis, or both.
Materials and Methods
The contrast material used in this study 
was provided by Bayer Healthcare 





Ecc = peak regional systolic circumferential strain
ECV = extracellular volume
FD = fractal dimension
LGE = late gadolinium enhancement
LV = left ventricle
LVNC = LV noncompaction cardiomyopathy
MESA = Multi-Ethnic Study of Atherosclerosis
NCC = ratio of noncompacted to compacted myocardium
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Advances in Knowledge
 n In the Multi-Ethnic Study of Ath-
erosclerosis (MESA) cohort, 
greater trabeculation of the left 
ventricle (LV) is associated with 
worse myocardial strain (regres-
sion coefficient = 4.0% per unit 
fractal dimension [FD] increase 
in trabeculation, P , .001).
 n In the MESA cohort, greater LV 
trabeculation is not associated 
with myocardial fibrosis as mea-
sured with native and contrast 
material—enhanced T1 mapping 
cardiac MR imaging.
Implications for Patient Care
 n A total of 230 (21%) MESA par-
ticipants have excess LV trabecu-
lation exceeding the current diag-
nostic threshold for LV 
noncompaction disease when 
using fractal analysis with an FD 
cutoff of 1.3 or more.
 n Excess greater LV trabeculation is 
associated with decreased average 
regional myocardial function, as 
measured by myocardial strain.
The trabeculae carneae are a net-work of slim columns of myocar-dial cells covered by endocardial 
cells at the luminal surface of the left 
ventricle (LV) and right ventricle. Dur-
ing embryonic cardiac development, 
trabeculae form by invagination of car-
diomyocytes into the lumen (1). Trabec-
ulated myocardium increases cardiac 
output and facilitates oxygen supply 
prior to coronary vascularization. As 
the myocardium develops, trabeculae 
compact, leading to increased thickness 
of the compact myocardium that rep-
resents the major part of the myocar-
dial mass of the mature heart. Simulta-
neously, coronary vessels develop (1).
Abnormal trabecular compaction is 
a diagnostic imaging feature of LV non-
compaction cardiomyopathy (LVNC), 
which is a rare primary genetic cardio-
myopathy characterized by excess myo-
cardial trabeculation more than twice as 
thick as the underlying myocardial wall 
(2). LVNC is associated with heart fail-
ure, regional wall motion abnormalities, 
and myocardial fibrosis (3–11). However, 
patients without overt cardiovascular 
disease and with normal cardiac func-
tion frequently show excess trabecula-
tion; more than 30% of healthy individ-
uals have a ratio of noncompacted to 
compacted myocardium greater than 2.3 
(12). In such individuals, the clinical im-
portance of excess trabeculation as a sign 
of current or future disease expression 
is not currently understood. Mechanisti-
cally, it would seem likely that regions of 
hypertrabeculated myocardium may have 
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360 3 360 mm field of view; 192 3 183 
matrix; 8-mm section thickness; gener-
alized autocalibrating partially parallel 
acquisitions factor, two).
Image Evaluation
LV volumes and function were measured 
by using Cardiac Image Modeller soft-
ware (version 6.2; University of Auck-
land, Auckland, New Zealand) (20). FD 
was measured on short-axis cine steady-
state free precession images (Fig 2) 
(G.C., 6 years of experience in cardiac 
MR imaging), as described previously 
(17). In brief, after image segmentation 
to identify the endocardial border, FD 
of the endocardial border was calculated 
by using a box counting method. Maxi-
mal apical FD was the maximum value 
derived from the apical half of the LV 
stack. Thickness of the compact and 
noncompact (trabeculated) LV myocar-
dium was measured at end diastole on 
long-axis steady-state free precession 
images in the middle of eight LV regions 
(F.Z., N.K.; 6 and 8 years of experience 
in cardiac MR imaging, respectively) 
(12). Maximal NCC was calculated as the 
maximum value of the eight segments in 
patients in whom measurements were 
performed for all eight segments.
T1 mapping data were evaluated by 
using MASS research software (MASS 
V2010-EXP; Leiden University Medi-
cal Center, Leiden, the Netherlands) 
(C.Y.L., B.A.; 13 and 12 years of expe-
rience in cardiac MR imaging, respec-
tively). Extracellular volume (ECV) was 
calculated as follows (21):















Tagged short-axis sections were ana-
lyzed by using Harmonic Phase software 
(Diagnosoft, Palo Alto, Calif) (22). Peak 
8-mm section thickness; 2-mm section 
gap; 45°–70° flip angle). Tagged im-
ages were obtained with a segmented 
k-space electrocardiographically gated 
fast low-angle shot pulse sequence 
performed in three short-axis sections 
with two orthogonally oriented paral-
lel striped tags by using spatial modu-
lation of magnetization (3.5–7.2/2.5, 
360 3 360 mm field of view, 10° flip 
angle, 256 3 128 matrix, 10-mm section 
thickness, nine phase-encoding views 
per segment, 1.4 3 2.8 3 10.0 mm spa-
tial resolution, 25-msec temporal reso-
lution, 7-mm tag spacing). Participants 
without contraindications underwent 
LGE imaging 15 minutes after intrave-
nous bolus injection of gadopentetate 
dimeglumine (0.15 mmol per kilo-
gram of body weight, Magnevist; Bayer 
Healthcare Pharmaceuticals) to identify 
myocardial scar. As described previously 
(19), T1 mapping sequences included 
unenhanced and delayed images 12 and 
25 minutes after contrast material in-
jection by using a modified Look-Locker 
sequence consisting of 11 source images 
in 17 heartbeats (2.2/1.1; 35° flip angle; 
with a focal myocardial scar on LGE 
images were excluded since focal LGE 
is associated with regional myocardial 
dysfunction, which would otherwise 
confound the analysis. In addition, par-
ticipants with missing data and inade-
quate MR image quality that hampered 
analysis also were excluded (Fig 1).
In a previous publication (17), the 
range of FD and its determinants were 
described in 2547 subjects in the MESA 
population. The current study focuses 
on analysis of the relationship between 
FD and average regional myocardial 
function and that between FD and dif-
fuse myocardial fibrosis in a subset of 
these participants.
Cardiovascular MR Imaging
Cardiac MR examinations were per-
formed at the six MESA field centers 
with 1.5-T MR imagers, as described 
previously (18,19). In brief, electrocar-
diographically gated long- and short-axis 
cine images were acquired by using a 
steady-state free precession sequence 
(repetition time msec/echo time msec, 
2.2/1.1; temporal resolution, 40 msec; 
Figure 1
Figure 1: Flowchart shows participant enrollment. Incl. = including, w/o = without.
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(model 2: systolic blood pressure, hy-
pertension, smoking, diabetes mellitus, 
high-density lipoprotein level, lipid-low-
ering medication use, and total choles-
terol level) and for cardiac MR measures 
(model 3, LV end-diastolic volume and 
LV ejection fraction). Models including 
precontrast T1 time were additionally ad-
justed for heart rate.
P , .05 was considered to indi-
cate a significant difference. Statistical 
analysis was performed by using SPSS 
(version 23; SPSS, Cary, NC) and STA-
TA (version 14.0; STATA, College Sta-
tion, Tex) statistical software.
Results
Participant Characteristics
Table 1 shows the population charac-
teristics, traditional cardiovascular risk 
factors, and mean 6 standard deviation 
deviation, and categorical variables are 
given as frequencies and percentages.
The missing data approach was 
complete case analysis, which uses only 
participants who have all variables ob-
served. To avoid bias when calculating 
mean Ecc, only those patients in whom 
it was feasible to measure Ecc in all 12 
segments were included.
Associations between the indepen-
dent variable FD and the dependent 
variables Ecc, T1 time, and ECV were 
assessed by using linear regression in uni-
variate and multivariable models per sub-
ject. Additionally, regression analysis was 
performed with NCC instead of FD as an 
independent variable. Normality of de-
pendent variables was assessed with the 
Shapiro-Wilk test. Multivariable models 
were adjusted for demographic covari-
ates (model 1), including age, sex, eth-
nicity, height, and weight, Additionally, 
for traditional cardiovascular risk factors 
regional systolic circumferential strain 
(Ecc) was calculated for 12 segments: 
the anterior, inferior, septal, and lat-
eral segments at the basal, midcavity, 
and apical levels (23). Mean peak Ecc 
was calculated as the mean of the 12 
segments in patients in whom mea-
surements were performed in all 12 
segments. Ecc is a negative value; there-
fore, lower (more negative) values indi-
cate greater circumferential strain and 
thus better regional function.
Statistical Analyses
Demographic indexes, cardiovascular 
risk factors, and cardiac MR measure-
ments of volume and function were eval-
uated for the entire cohort and were 
compared across quartiles of FD by 
using one-way analysis of variance for 
continuous covariates and the x2 test for 
categorical covariates. Continuous vari-
ables are presented as mean 6 standard 
Figure 2
Figure 2: Analysis of MR images of FD. FD was measured via fractal analysis of short-axis cine steady-state free precession images in four exemplar subjects from 
the MESA cohort: one subject with low FD (top) and three subjects with high FD (rows 2, 3, and 4). Colored lines show contouring of endocardial borders. FD indicates 
how extensively the contour fills two-dimensional space. The image on the left shows planning of the short-axis cine stack. Numbers on top of each short-axis image 
indicate the FD of the respective section. Colored panels on the right give characteristics of the four subjects. AfrcAm = African American, BMI = body mass index, 
Hisp = Hispanic, HT med = hypertension medication, N = no, SBP = systolic blood pressure, Y = yes.
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diabetes, had higher systolic blood pres-
sure on average, and were more likely 
to be smokers. In quartiles with higher 
FD, mean high-density lipoprotein cho-
lesterol level tended to be lower. There 
were no significant differences in LV end 
diastolic volume and LV ejection fraction 
between quartiles of FD. Circumferen-
tial strain tended to be more positive 
(indicating worse regional function) with 
increasing FD quartile (Fig 3).
Relationship between Trabeculation and 
Circumferential Strain
In univariate analysis, a higher maximal 
apical FD was associated with more pos-
itive peak global circumferential strain 
(indicating worse average regional func-
tion) (regression coefficient [B] = 6.6%, 
P , .001). The association persisted 
after adjustment for demographic co-
variates (B = 4.0%, P , .001) and tra-
ditional cardiovascular risk factors (B = 
3.6%, P , .001) and after adjustment 
for cardiac MR measures of LV vol-
ume and function (B = 2.8%, P = .002) 
(Table 3). In the fully adjusted model, 
age, male sex, weight, diabetes mellitus, 
and systolic blood pressure also were as-
sociated with more positive (worse) cir-
cumferential strain (Table 4).
In an analysis parallel to that per-
formed for FD, in 745 individuals with 
complete data, there was no relation-
ship between the conventional measure 
of trabeculation (NCC) in the fully ad-
justed model (P = .073).
Relationship between FD and T1 Time and 
between FD and ECV
In univariate analysis and multivariable 
models (n = 992), maximal apical FD 
was not associated with unenhanced 
T1 time, nor was it associated with T1 
time at 12 or 25 minutes after contrast 
material administration. There was no 
association of FD with ECV persisting 
in multivariable analysis.
NCC was not associated with unen-
hanced or contrast-enhanced T1 times (n 
= 650) or ECV (n = 372) (P . .05 for all).
Discussion
Steady-state free precession cine car-
diac MR images readily depict variations 
A total of 230 (20.5%) of 1123 
subjects had an FD of 1.3 or higher, 
which was considered the threshold for 
LVNC when using fractal analysis (14). 
For comparison, 247 (33.2%) of 745 
subjects had an NCC greater than 2.3, 
which was considered the cutoff for 
LVNC at cardiac MR imaging (13).
Table 2 shows patient characteris-
tics, traditional risk factors, and cardiac 
MR measures stratified by FD. Partici-
pants with a higher FD were more likely 
to be male and of African American or 
Hispanic ethnicity, while the proportion 
of Asian (predominantly of Chinese de-
scent) participants was higher in the 
lower quartiles. Subjects in the quartiles 
with higher FD were taller, had a higher 
body weight, were more likely to have 
of cardiac MR variables for subjects in-
cluded in the analysis of the relationship 
between trabeculation and strain and 
that between trabeculation and T1 time. 
There were no clinically relevant differ-
ences in demographics between the sub-
sets of subjects included in the analysis 
and the 1840 subjects in the MESA 5 
cohort who underwent a cardiac MR ex-
amination including LGE imaging. Mean 
FD was 1.2 6 0.07. Mean NCC was 2.1 
6 0.68. Mean Ecc was 218.3 6 2.27. 
Mean T1 times were 974.7 msec 6 42.1 
before contrast material administration, 
455.3 msec 6 40.0 at 12 minutes after 
contrast material administration, and 
518.8 msec 6 40.2 at 25 minutes after 
contrast material administration. Mean 
ECV was 0.27 6 0.3.
Table 1
Characteristics of the MESA Study Cohort
Characteristic
Subjects with Complete FD and  
Ecc Measurements (n = 1123)
Subjects with Complete FD and  
T1 Measurements (n = 992)
Female sex 593 (52.8) 521 (52.5)
Age (y)* 67.1 6 8.7 (54–93) 67.1 6 8.7 (54–93)
Ethnicity
 White 515 (45.9) 519 (52.3)
 Asian, predominantly Chinese 124 (11.0) 114 (11.5)
 African American 251 (22.4) 220 (22.2)
 Hispanic 233 (20.7) 139 (14.0)
Height (cm)* 166.1 6 9.7 166.7 6 9.8
Weight (kg)* 77.4 6 16.5 78.6 6 17.3
HDL cholesterol level (mg/dL)* 55.5 6 16.2 55.2 6 16.3
Total cholesterol level (mg/dL)* 184.6 6 35.8 183.3 6 36.3
Lipid-lowering medication use 396 (35.3) 364 (36.7)
Diabetes mellitus 178 (15.9) 150 (15.1)
Systolic blood pressure (mmHg)* 121.8 6 19.4 121.1 6 18.7
Hypertension medication use 526 (46.8) 476 (48.0)
Smokers 573 (51.0) 526 (53.0)
LV end diastolic volume (mL)* 124.0 6 30.1 123.6 6 30.6
LV ejection fraction (%)* 62.2 6 6.5 62.4 6 6.6
Mean Ecc (%)* 218.3 6 2.27 NA
FD* 1.2 6 0.07 1.2 6 0.07
T1 precontrast (msec)* NA 974.7 6 42.1
T1 at 12 minutes (msec)* NA 455.3 6 40.0
T1 at 25 minutes (msec)* NA 518.8 6 40.2
ECV* NA 0.27 6 0.3†
Note.—Unless otherwise indicated, data are number of subjects, with the percentage in parentheses. HDL = high-density 
lipoprotein, NA = not applicable, T1 precontrast = myocardial T1 time prior to contrast material administration, T1 at 12 minutes = 
myocardial T1 time 12 minutes after contrast material administration, T1 at 25 minutes = myocardial T1 time 25 minutes after 
contrast material administration.
* Data are means 6 standard deviation.
† n = 544.
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the degree of trabeculation seems to 
be related to disease severity. By using 
in the degree of trabeculation of the LV. 
In patients with genetic LVNC disease, 
Table 2
Characteristics of the MESA Study Cohort for Quartiles of Maximal Apical FD
Characteristic Quartile 1 Quartile 2 Quartile 3 Quartile 4
P Value for  
All Quartiles
P Value for Quartile 1 
vs Quartile 4
Female 170 (60.7) 163 (58.0) 148 (52.7) 112 (39.9) ,.001* ,.001*
Age (y)† 67.4 6 8.5 65.8 6 8.4 66.9 6 8.7 68.4 6 9.0 .003* .170
Ethnicity
 White 137 (48.9) 128 (45.6) 131 (46.6) 119 (42.3) .469 .118
 Asian 46 (16.4) 39 (13.9) 26 (9.3) 13 (4.6) ,.001* ,.001*
  African American 54 (19.3) 57 (20.3) 65 (23.1) 75 (26.7) .148 .037*
 Hispanic 43 (15.4) 57 (20.3) 59 (21.0) 74 (26.3) .016* .001*
Height (cm)† 164.7 6 9.6 165.4 6 9.6 166.7 6 10.1 167.5 6 9.4 .002* ,.001*
Weight (kg)† 73.4 6 16.9 74.6 6 14.1 78.8 6 17.1 82.6 6 16.3 ,.001* ,.001*
HDL cholesterol level (mg/dL)† 57.3 6 17.1 56.7 6 16.5 55.4 6 15.8 52.7 6 14.9 .004* .001*
Total cholesterol level (mg/dL)† 186.8 6 38.2 185.4 6 34.1 185.6 6 34.6 180.5 6 36.1 .162 .045*
Lipid-lowering medication use 92 (32.9) 96 (34.2) 92 (32.7) 116 (41.3) .107 .039*
Diabetes mellitus 40 (14.3) 30 (10.7) 43 (15.3) 65 (23.1) .001* .007*
Systolic blood pressure (mmHg)† 120.0 6 18.0 120.0 6 19.5 122.1 6 18.8 125.3 6 20.9 .003* .001*
Hypertension medication use 117 (41.8) 125 (44.5) 121 (43.1) 163 (58.0) ,.001* ,.001*
Smokers 135 (48.2) 137 (48.8) 140 (49.8) 161 (57.3) .109 .031*
LV EDV (mL)† 121.3 6 28.4 123.3 6 26.9 126.4 6 31.1 125.0 6 33.4 .216 .164
LV EF (%)† 62.4 6 5.9 62.5 6 6.2 62.2 6 6.8 61.8 6 7.1 .523 .244
Ecc (%)† 218.7 6 2.1 218.6 6 2.1 218.3 6 2.4 217.5 6 2.3 ,.001* ,.001*
Note.—Unless otherwise indicated, data are number of subjects, with the percentage in parentheses. We had complete data for 1123 subjects. Quartile 1, FD = 1.01–1.15; quartile 2, FD = 1.15–1.12; 
quartile 3, FD = 1.12–1.24; and quartile 4, FD = 1.24–1.4. EDV = end-diastolic volume, EF = left ventricular ejection fraction, HDL = high-density lipoprotein.
* Difference was significant.
† Data are means 6 standard deviation.
Figure 3
Figure 3: Graph shows circumferential strain by quartiles of FD. Quartile 1, 
FD = 1.01–1.15; quartile 2, FD = 1.15–1.12; quartile 3, FD = 1.12–1.24; and 
quartile 4, FD = 1.24–1.4. Error bars indicate the 95% confidence interval.
fractal analysis, we have shown that 
average regional myocardial function 
is worse in subjects with greater LV 
trabeculation. Interestingly, greater 
trabeculation was not associated with 
diffuse myocardial fibrosis, as measured 
by alteration in T1 time. These results 
suggest a mechanical link between LV 
trabeculation and the effectiveness of 
myocardial function.
Relationship between LV Trabeculation 
and Average Regional Myocardial Function
The present study supports the hypo-
thesis that LV function is at least in 
part dependent on the degree of tra-
beculated myocardium. In the MESA 
cohort, subjects with highly trabeculat-
ed LV myocardium had worse average 
regional function. This relationship was 
found even after adjustment for demo-
graphic and clinical factors and global 
LV function. Of interest, greater NCC 
did not enable us to detect these re-
lationships. This supports accumulating 
evidence that, although NCC is easy to 
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(used as surrogate of diffuse myocardial 
fibrosis) than did healthy volunteers, in-
dependent of the presence of LGE.
In this context, our aim was to in-
vestigate the relationship between ex-
tent of trabeculation and diffuse myo-
cardial fibrosis by using T1 time and 
ECV, respectively, measured with car-
diac MR imaging as a surrogate. How-
ever, in our subset of study participants 
without known cardiovascular disease 
at enrollment, there was no association 
between trabeculation and native or 
contrast-enhanced T1 time or ECV.
Participants in our population-
based study had a broad spectrum of 
trabeculation. The FD in the highest 
quartile was between 1.24 and 1.45. 
A total of 230 (20.5%) of the 1123 
subjects had an FD of 1.3 or greater, 
previously defined as the threshold for 
LVNC, and 247 (33.2%) of 745 had 
an NCC greater than 2.3, still widely 
used as a cutoff for LVNC at cardiac 
MR imaging. This discrepancy is ex-
plained by a lack of diagnostic crite-
ria for an LVNC with high specificity. 
The current criteria focus on thickness 
strain was 218.3%. In our unadjusted 
analysis, a 0.1-unit increase in FD was 
associated with an absolute increase 
of 0.6% strain or approximately 3% of 
the mean value. Our sample size was 
sufficient to account for 14 additional 
variables that might affect regional 
function in multivariable models. Even 
in fully adjusted models, the association 
of greater trabeculation with worse av-
erage regional function remained sig-
nificant. Not surprisingly, less sensitive 
measures of trabeculation and function 
(NCC and ejection fraction, respec-
tively) did not reveal these associations.
Relationship between LV Trabeculation and 
Measures of Diffuse Myocardial Fibrosis
In previous publications, focal myo-
cardial fibrosis has been described as 
a feature of LVNC (4,5,8,10). Besides 
these reports of focal fibrosis or scars 
in patients with LVNC, Jenni et al (26) 
revealed interstitial fibrosis as a finding 
in six of seven hearts with a diagnosis of 
LVNC. Zhou et al (27) recently report-
ed subjects with a diagnosis of LVNC 
had a significantly longer native T1 time 
measure in the clinic, it is not specific 
(33.2% [247 of 745] of subjects in the 
MESA cohort with NCC . 2.3). In ad-
dition, NCC is a one-dimensional mea-
surement at a single point in the LV 
that does not comprehensively describe 
myocardial trabeculation. FD reflects 
myocardial complexity in a region of the 
myocardium in a fashion similar to the 
concept of average regional myocardial 
strain.
Zemrak et al (24) found that sub-
jects with an abnormal NCC had no 
deterioration of ejection fraction in 
the prior 10 years. However, it is well 
known that ejection fraction can be 
normal while myocardial strain is im-
paired (eg, as in the case of heart fail-
ure with preserved ejection fraction). 
It remains unknown if a subject with 
hypertrabeculation and impaired strain 
will subsequently develop deterioration 
of global function and clinical symp-
toms or if myocardial dysfunction will 
remain stable and subclinical.
In this cohort, average FD in the 
myocardial apex was 1.2. Captur et al 
(14) previously reported patients with 
LVNC disease have an FD greater than 
1.3, indicating small changes in FD may 
be clinically meaningful. Similarly, myo-
cardial strain is a sensitive measure of 
LV function, and strain is highly con-
served in healthy subjects (25). In the 
current study, the mean circumferential 
Table 3
Relationship of Maximal Apical FD to 
Mean Ecc
Analysis B Value P Value
Univariate 6.556 ,.001
Multivariable model 1 4.045 ,.001
Multivariable model 2 3.623 ,.001
Multivariable model 3 2.838 .002
Note.—Dependent variable, Ecc; B, unstandardized 
regression coefficient indicating the absolute difference in 
Ecc (%) related to a change of one unit of maximal apical 
FD. Model 1 was adjusted for age, sex, ethnicity, height, 
and weight. Model 2 was additionally adjusted for systolic 
blood pressure, hypertension, smoking, diabetes mellitus, 
high-density lipoprotein level, lipid-lowering medication 
use, and total cholesterol level. Model 3 was additionally 
adjusted for LV end-diastolic volume and LV ejection 
fraction. For detailed analysis of the relationship between 
all covariates and circumferential strain, see Table 4.
Table 4
Relationship of Maximal Apical FD and Covariates to Ecc in the Fully Adjusted 
Multivariable Model
Variable B Value b Level P Value
FD 2.838 0.088 .002*
Age 0.017 0.064 .037*
Male sex 0.874 0.192 ,.001*
Asian ethnicity 20.312 20.043 .179
African American ethnicity 0.015 0.003 .924
Hispanic ethnicity 20.435 20.078 .014*
Height 0.011 0.045 .342
Weight 0.036 0.263 ,.001*
HDL cholesterol level 0.005 0.035 .265
Total cholesterol level 0.001 0.020 .534
Lipid-lowering medication use 0.205 0.043 .143
Diabetes mellitus 0.424 0.068 .018*
Systolic blood pressure 0.015 0.125 ,.001*
Hypertension medication use 20.020 20.004 .881
Smoker 0.152 0.034 .230
LV end-diastolic volume 20.024 20.324 ,.001*
LV ejection fraction 20.067 20.193 ,.001*
Note.—Dependent variable, Ecc; B, unstandardized regression coefficient indicating the absolute difference in Ecc (%) related 
to a change of one unit of the independent variables. HDL = high-density lipoprotein.
* Difference was significant.
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sion of the current criteria is required 
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A limitation of this study was the 
cross-sectional design, which precluded 
a causal interpretation of the results. It 
remains unclear if hypertrabeculation 
leads to a deterioration of average re-
gional function or if increased trabecu-
lation might be an adaptive process 
resulting from impaired function. The 
latter would be of biologic interest, as 
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throughout life as a consequence of car-
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conditions. The present data indicate 
that hypertrabeculation might be an epi-
phenomenon of disease associated with 
impaired average regional function.
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